O33 Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis
oleh: Richard A Furie, Sander W Tas, Edward M Vital, Ana Malvar, Thomas Schindler, Harini Raghu, Cary M Looney, Jorge A Ross Terres, Veronica G Anania, Ashley Mao, Elsa Martins
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2024-03-01 |
Deskripsi
No description available for this item.